Josep Piulats, M.D., PhD, Catalan Cancer Institute discusses TRITON2 Trial, Rucaparib PARP Inhibitor Data. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
TRITON2 Trial, Rucaparib PARP Inhibitor Data
Josep Piulats, M.D., PhD, Catalan Cancer Institute discusses TRITON2 Trial, Rucaparib PARP Inhibitor Data. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.